| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1043858
[patent_doc_number] => 06867292
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-15
[patent_title] => 'Characterization of novel gene cbl-SL'
[patent_app_type] => utility
[patent_app_number] => 09/434708
[patent_app_country] => US
[patent_app_date] => 1999-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 20402
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/867/06867292.pdf
[firstpage_image] =>[orig_patent_app_number] => 09434708
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/434708 | Characterization of novel gene cbl-SL | Nov 4, 1999 | Issued |
Array
(
[id] => 352368
[patent_doc_number] => 07491388
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-02-17
[patent_title] => 'Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation'
[patent_app_type] => utility
[patent_app_number] => 09/807810
[patent_app_country] => US
[patent_app_date] => 1999-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 4248
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/491/07491388.pdf
[firstpage_image] =>[orig_patent_app_number] => 09807810
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/807810 | Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation | Nov 3, 1999 | Issued |
Array
(
[id] => 1338203
[patent_doc_number] => 06585973
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-01
[patent_title] => 'Method for preparing solid phase conjugated vaccine'
[patent_app_type] => B1
[patent_app_number] => 09/428498
[patent_app_country] => US
[patent_app_date] => 1999-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10203
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/585/06585973.pdf
[firstpage_image] =>[orig_patent_app_number] => 09428498
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/428498 | Method for preparing solid phase conjugated vaccine | Oct 27, 1999 | Issued |
Array
(
[id] => 749276
[patent_doc_number] => 07022483
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-04-04
[patent_title] => 'Methods for identifying and isolating antigen-specific T cells'
[patent_app_type] => utility
[patent_app_number] => 09/421506
[patent_app_country] => US
[patent_app_date] => 1999-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 58
[patent_no_of_words] => 37164
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/022/07022483.pdf
[firstpage_image] =>[orig_patent_app_number] => 09421506
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/421506 | Methods for identifying and isolating antigen-specific T cells | Oct 18, 1999 | Issued |
Array
(
[id] => 1408167
[patent_doc_number] => 06528307
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-04
[patent_title] => 'Cytolytic T-cell clones against colorectal carcinoma'
[patent_app_type] => B1
[patent_app_number] => 09/403310
[patent_app_country] => US
[patent_app_date] => 1999-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 11341
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/528/06528307.pdf
[firstpage_image] =>[orig_patent_app_number] => 09403310
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/403310 | Cytolytic T-cell clones against colorectal carcinoma | Oct 17, 1999 | Issued |
Array
(
[id] => 4181903
[patent_doc_number] => 06159723
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Renin-active substance'
[patent_app_type] => 1
[patent_app_number] => 9/417305
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5160
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/159/06159723.pdf
[firstpage_image] =>[orig_patent_app_number] => 417305
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/417305 | Renin-active substance | Oct 12, 1999 | Issued |
Array
(
[id] => 1238568
[patent_doc_number] => 06685936
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-02-03
[patent_title] => 'Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation'
[patent_app_type] => B2
[patent_app_number] => 09/415627
[patent_app_country] => US
[patent_app_date] => 1999-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4483
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/685/06685936.pdf
[firstpage_image] =>[orig_patent_app_number] => 09415627
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/415627 | Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation | Oct 11, 1999 | Issued |
| 09/415854 | ISOAGGLUTININ-DEPLETED BLOOD COMPOSITIONS AND METHODS OF MAKING SAME | Oct 7, 1999 | Abandoned |
Array
(
[id] => 1564282
[patent_doc_number] => 06338836
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-15
[patent_title] => 'Asthma analysis method employing hyperpolarized gas and magnetic resonance imaging'
[patent_app_type] => B1
[patent_app_number] => 09/406372
[patent_app_country] => US
[patent_app_date] => 1999-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2223
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/338/06338836.pdf
[firstpage_image] =>[orig_patent_app_number] => 09406372
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/406372 | Asthma analysis method employing hyperpolarized gas and magnetic resonance imaging | Sep 27, 1999 | Issued |
| 09/269922 | USE OF AN IMMUNOGLOBULIN PREPARATION FOR PRODUCING AN ORAL MEDICAMENT PREVENTING HEMOLYTIC UREMIC SYNDROME AND PREPARATION FOR THE SAME | Sep 26, 1999 | Abandoned |
Array
(
[id] => 7390065
[patent_doc_number] => 20040037839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'T-CELL RECEPTOR BETA-LIKE PROTEIN'
[patent_app_type] => new
[patent_app_number] => 09/405940
[patent_app_country] => US
[patent_app_date] => 1999-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19019
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20040037839.pdf
[firstpage_image] =>[orig_patent_app_number] => 09405940
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/405940 | T-CELL RECEPTOR BETA-LIKE PROTEIN | Sep 26, 1999 | Abandoned |
Array
(
[id] => 1030977
[patent_doc_number] => 06878528
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-12
[patent_title] => 'Polynucleotides encoding a mammalian Langerhans cell antigen'
[patent_app_type] => utility
[patent_app_number] => 09/787192
[patent_app_country] => US
[patent_app_date] => 1999-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23245
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/878/06878528.pdf
[firstpage_image] =>[orig_patent_app_number] => 09787192
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/787192 | Polynucleotides encoding a mammalian Langerhans cell antigen | Sep 22, 1999 | Issued |
Array
(
[id] => 7219477
[patent_doc_number] => 20040072153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'PASTEURELLA NEURAMINIDASE CODING SEQUENCES, COMPOSITIONS AND DIAGNOSTIC METHODS'
[patent_app_type] => new
[patent_app_number] => 09/400122
[patent_app_country] => US
[patent_app_date] => 1999-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11935
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072153.pdf
[firstpage_image] =>[orig_patent_app_number] => 09400122
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/400122 | Pasteurella neuraminidase diagnostic methods and immunoassay kit | Sep 20, 1999 | Issued |
Array
(
[id] => 4404302
[patent_doc_number] => 06228363
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Peptides for the treatment of systemic lupus erythematosus'
[patent_app_type] => 1
[patent_app_number] => 9/399494
[patent_app_country] => US
[patent_app_date] => 1999-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 4417
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228363.pdf
[firstpage_image] =>[orig_patent_app_number] => 399494
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/399494 | Peptides for the treatment of systemic lupus erythematosus | Sep 19, 1999 | Issued |
Array
(
[id] => 1506010
[patent_doc_number] => 06440426
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Antigen-containing formulation and methods of use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/399217
[patent_app_country] => US
[patent_app_date] => 1999-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6468
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/440/06440426.pdf
[firstpage_image] =>[orig_patent_app_number] => 09399217
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/399217 | Antigen-containing formulation and methods of use thereof | Sep 16, 1999 | Issued |
Array
(
[id] => 4233409
[patent_doc_number] => 06165735
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-26
[patent_title] => 'Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 9/397979
[patent_app_country] => US
[patent_app_date] => 1999-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29054
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/165/06165735.pdf
[firstpage_image] =>[orig_patent_app_number] => 397979
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/397979 | Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof | Sep 15, 1999 | Issued |
| 09/393652 | METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF GRAFT REJECTION USING HEAT SHOCK PROTEINS | Sep 9, 1999 | Abandoned |
Array
(
[id] => 322297
[patent_doc_number] => 07517527
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-14
[patent_title] => 'Immunotoxin with in vivo T cell suppressant activity and methods of use'
[patent_app_type] => utility
[patent_app_number] => 09/389565
[patent_app_country] => US
[patent_app_date] => 1999-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 22
[patent_no_of_words] => 19563
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/517/07517527.pdf
[firstpage_image] =>[orig_patent_app_number] => 09389565
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/389565 | Immunotoxin with in vivo T cell suppressant activity and methods of use | Sep 2, 1999 | Issued |
Array
(
[id] => 6174501
[patent_doc_number] => 20020155118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'ALKALOID GLYCOSIDE FOR USE AS A MEDICAMENT'
[patent_app_type] => new
[patent_app_number] => 09/242442
[patent_app_country] => US
[patent_app_date] => 1999-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4287
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20020155118.pdf
[firstpage_image] =>[orig_patent_app_number] => 09242442
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/242442 | Alkaloid glycoside for use as a medicament | Aug 26, 1999 | Issued |
| 09/383372 | USE OF ENDOTHELIN INHIBITORS FOR TREATMENT OR PREVENTION FIBROTIC DISORDERS | Aug 25, 1999 | Abandoned |